212 related articles for article (PubMed ID: 22624643)
1. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs.
Rasekaba TM; Lim WK; Hutchinson AF
Aust Health Rev; 2012 May; 36(2):205-12. PubMed ID: 22624643
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
[TBL] [Abstract][Full Text] [Related]
3. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
4. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.
Morsanutto A; Berto P; Lopatriello S; Gelisio R; Voinovich D; Cippo PP; Mantovani LG
J Diabetes Complications; 2006; 20(3):163-9. PubMed ID: 16632236
[TBL] [Abstract][Full Text] [Related]
5. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
6. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization and re-hospitalization of people with and without diabetes in La Plata, Argentina: comparison of their clinical characteristics and costs.
Gagliardino JJ; Martella A; Etchegoyen GS; Caporale JE; Guidi ML; Olivera EM; González C
Diabetes Res Clin Pract; 2004 Jul; 65(1):51-9. PubMed ID: 15163478
[TBL] [Abstract][Full Text] [Related]
8. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
9. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Amin AN; Jhaveri M; Lin J
Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
[TBL] [Abstract][Full Text] [Related]
10. A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets.
Steuten LM; Vrijhoef HJ; Landewé-Cleuren S; Schaper N; Van Merode GG; Spreeuwenberg C
Diabet Med; 2007 Oct; 24(10):1112-20. PubMed ID: 17672862
[TBL] [Abstract][Full Text] [Related]
11. Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective.
Drabik A; Büscher G; Sawicki PT; Thomas K; Graf C; Müller D; Stock S
Diabetes Res Clin Pract; 2012 Feb; 95(2):194-200. PubMed ID: 22004943
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic correlates of inpatient spending for patients with type 2 diabetes mellitus in China: evidence from Hangzhou.
Li H; Chen BK; Shah N; Wang Z; Eggleston KN
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):35-44. PubMed ID: 22237582
[TBL] [Abstract][Full Text] [Related]
13. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
14. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
[TBL] [Abstract][Full Text] [Related]
15. [The costs of diabetes mellitus and its complications in Germany].
Hauner H
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S240-2. PubMed ID: 17139578
[TBL] [Abstract][Full Text] [Related]
16. Predictors of government subsidized pharmaceutical use in patients with diabetes or cardiovascular disease in a primary care setting: evidence from a prospective randomized trial.
Hirst NG; Whitty JA; Synnott RL; Eley DS; Scuffham PA
J Med Econ; 2011; 14(6):698-704. PubMed ID: 21892854
[TBL] [Abstract][Full Text] [Related]
17. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus.
Rosenzweig JL; Weinger K; Poirier-Solomon L; Rushton M
Am J Manag Care; 2002 Nov; 8(11):950-8. PubMed ID: 12437310
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
Bolin K; Gip C; Mörk AC; Lindgren B
Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
[TBL] [Abstract][Full Text] [Related]
19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
20. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
